-
Could a new combined oral contraceptive (OC) be available to U.S. women? Organon is conducting two Phase 3a trials for the first monophasic oral contraceptive containing estradiol (E2) and a new progestin, nomegestrol acetate (NOMAC).
-
Review the number of sexually transmitted diseases (STDs) detected in your patient population over the last year.
-
New research indicates that a rapid test that uses self-collected vaginal swabs may be effective in diagnosing chlamydia.1 With its ability to deliver results in less than 30 minutes, the test, now in development, would give clinicians a same-day diagnostic and screening tool for chlamydial infection.
-
While you may be comfortable with menstrual suppression through use of continuous oral contraceptives (OCs), are your patients? According to results from a national survey, more than 66% of women say that they are interested in suppressing their menstrual periods, but many of them aren't sure if it's safe.
-
What is your level of knowledge when it comes to genital herpes, its methods of virus transmission, risks to others, and appropriate treatment? If results of an online survey are any indication, many health care providers and patients with herpes are poorly informed about herpes.
-
-
An elevated white blood cell count is a risk factor for several cancers in women.
-
When whole grain cereal (WGC) is consumed regularly, there is a lower risk of developing heart failure (HF). This association is likely to be linked to the beneficial effects of WGC on risk factors (ie, hypertension, obesity, hyperlipidemia) rather than HF itself.
-
-
12-lead ECG obtained from a 50-year old African American man with hypertension and chest pain.
